Clinical trial
Glaser Obesity Study
NCT00209482 · Glaser Pediatric Research Network, Other · Unknown status
Key facts
| NCT number | NCT00209482 |
|---|---|
| Title | Glaser Obesity Study |
| Official title | A Multi-Center, Randomized, Placebo Controlled, Double Blind Trial of Metformin in Obese Adolescents. |
| Lead sponsor | Glaser Pediatric Research Network, Other |
| Collaborators | Elizabeth Glaser Pediatric AIDS Foundation |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | glucophage XR |
| Enrollment | 76 |
| Start date | Oct 1, 2003 |
| Completion | Nov 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 5, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: